Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Paula Vaz Cardoso, Ludimila ^a   Dias, Ronaldo F ^b   Freitas, Aline A ^a   Hungria, Emerith M ^a   Oliveira, Regiane M ^a   Collovati, Marco ^b   Reed, Steven G ^c   Duthie, Malcolm S ^c   Martins Araújo Stefani, Mariane ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b Orange Life   (Brazil)

^c INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

Author keywords

Brazil; Lateral flow; Leprosy; Serologic response

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PYROXYLIN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MULTIBACILLARY LEPROSY; MYCOBACTERIUM LEPRAE; OBJECT MANIPULATION; PREDICTIVE VALUE; PROGNOSIS; QUANTITATIVE ANALYSIS; RAPID TEST; SENSITIVITY AND SPECIFICITY; SEROLOGY; TELEPHONE; ADOLESCENT; BLOOD; CHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEPROSY, MULTIBACILLARY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; MOBILE PHONE; PROCEDURES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIOLOGICAL TECHNIQUES; CELL PHONES; FEMALE; HUMANS; IMMUNOCHROMATOGRAPHY; LEPROSY, MULTIBACILLARY; MALE; MIDDLE AGED; MYCOBACTERIUM LEPRAE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84887024002     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-497     Document Type: Article

References (37)

1. Ridley DS, Jopling WH. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966, 34:255-273.
2. Modlin RL. The innate immune response in leprosy. Curr Opin Immunol 2010, 22(1):48-54. 10.1016/j.coi.2009.12.001, 2882026, 20060279.
3. Scollard DM. The biology of nerve injury in leprosy. Lepr Rev 2008, 79(3):242-253.
4. Siddiqui MR, Velidi NR, Pati S, Rath N, Kanungo AK, Bhanjadeo AK, Rao BB, Ojha BM, Krishna Moorthy K, Soutar D, Porter JD, Ranganadha Rao PV. Integration of leprosy elimination into primary health care in orissa, India. PLoS One 2009, 18(12):e8351.
5. Correa RDA, Aquino DM, Caldas AJ, Amaral DK, França FS, Mesquita ER. Epidemiological, clinical, and operational aspects of leprosy patients assisted at a referral service in the state of Maranhão, Brazil. Rev Soc Bras Med Trop 2012, 45(1):89-94. 10.1590/S0037-86822012000100017, 22370835.
6. Stefani MM, Grassi AB, Sampaio LH, Sousa AL, Costa MB, Scheelbeek P, Neupane KD, Hagge DA, Macdonald M, Cho SN, Oskam L, Bührer-Sékula S. Comparison of two rapid tests for anti-phenolic glycolipid-I serology in Brazil and Nepal. Mem Inst Oswaldo Cruz 2012, 107(Suppl):124-131.
7. Klatser PR, Cho SN, Brennan PJ. The contribution of serological tests to leprosy control. Int J Lepr Other Mycobact Dis 1996, 64(Suppl):S63-S67.
8. Bührer-Sékula S, Smits HL, Gussenhoven GC, van Leeuwen J, Amador S, Fujiwara T, Klatser PR, Oskam L. Simple and fast lateral flow test for classification of leprosy patients and identification of contacts with high risk of developing leprosy. J Clin Microbiol 2003, 41(5):1991-1995. 10.1128/JCM.41.5.1991-1995.2003, 154748, 12734239.
9. Reece ST, Ireton G, Mohamath R, Guderian J, Goto W, Gelber R, Groathouse N, Spencer J, Brennan P, Reed SG. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy. Clin Vaccine Immunol 2006, 13(3):333-340. 10.1128/CVI.13.3.333-340.2006, 1391965, 16522774.
10. Duthie MS, Goto W, Ireton GC, Reece ST, Cardoso LP, Martelli CM, Stefani MM, Nakatani M, de Jesus RC, Netto EM, Balagon MV, Tan E, Gelber RH, Maeda Y, Makino M, Hoft D, Reed SG. Use of protein antigens for early serological diagnosis of leprosy. Clin Vaccine Immunol 2007, 14:1400-1408. 10.1128/CVI.00299-07, 2168166, 17898185.
11. Sampaio LH, Stefani MM, Oliveira RM, Sousa AL, Ireton GC, Reed SG, Duthie MS. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development. BMC Infect Dis 2011, 11:26-37. 10.1186/1471-2334-11-26, 3040138, 21269435.
12. Hungria EM, Oliveira RM, Souza AL, Costa MB, Souza VN, Silva EA, Moreno FR, Nogueira ME, Costa MR, Silva SM, Bührer-Sékula S, Reed SG, Duthie MS, Stefani MM. Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil. Mem Inst Oswaldo Cruz 2012, 107(Suppl):S104-S111.
13. Rada E, Duthie MS, Reed SG, Aranzazu N, Convit J. Serologic follow-up of IgG responses against recombinant mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela. Mem Inst Oswaldo Cruz 2012, 107(Suppl):90-94.
14. Qiong-Hua P, Zhong-Yi Z, Jun Y, Yan W, Lian-Chao Y, Huan-Ying L, Reed SG, Duthie MS. Early Revelation of Leprosy in China by Sequential Antibody Analyses with LID-1 and PGL-I. J Trop Med 2013, 2013:352689. 3568865, 23431316.
15. Duthie MS, Truman RW, Goto W, O'Donnell J, Hay MN, Spencer JS, Carter D, Reed SG. Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos. Clin Vaccine Immunol 2011, 18(2):254-259. 10.1128/CVI.00420-10, 3067361, 21177914.
16. Spencer JS, Duthie MS, Geluk A, Balagon MF, Kim HJ, Wheat WH, Chatterjee D, Jackson M, Li W, Kurihara JN, Maghanoy A, Mallari I, Saunderson P, Brennan PJ, Dockrell HM. Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy. Mem Inst Oswaldo Cruz 2012, 107(Suppl):79-89.
17. Brett SJ, Payne SN, Gigg J, Burgess P, Gigg R. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy. Clin Exp Immunol 1986, 64(3):476-483. 1542453, 2431812.
18. Bührer-Sékula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JA, Vieira LM, de Matos HJ, Faber WR, Klatser PR. Use of ML dipstick as a tool to classify leprosy patients. Int J Lepr Other Mycobact Dis 2000, 68:456-463.
19. Cho SN, Fujiwara T, Hunter SW, Rea TH, Gelber RH, Brennan PJ. Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy. J Infect Dis 1984, 150(3):311-322. 10.1093/infdis/150.3.311, 6207246.
20. Fujiwara T, Hunter SW, Cho SN, Aspinall GO, Brennan PJ. Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect Immun 1984, 43(1):245-252. 263417, 6360898.
21. Lee DS, Jeon BG, Ihm C, Park JK, Jung MY. A simple and smart telemedicine device for developing regions: a pocket-sized colorimetric reader. Lab Chip 2011, 7:120-126.
22. Mudanyali O, Dimitrov S, Sikora U, Padmanabhan S, Navruz I, Ozcan A. Integrated rapid-diagnostic-test reader platform on a cellphone. Lab Chip 2012, 7(15):2678-2686.
23. Svanholm H, Starklint H, Gundersen HJ, Fabricius J, Barlebo H, Olsen S. Reproducibility of histomorphologic diagnoses with special reference to the Kappa statistic. APMIS 1989, 97:689-698. 10.1111/j.1699-0463.1989.tb00464.x, 2669853.
24. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986, 110(1):13-20. Erratum in: Arch Pathol Lab Med 1986, 110(10):958.
25. World Health Organization (WHO), New Delhi, India WHO Weekly epidemiological record - Global strategy for further reducing the leprosy burden and sustaining leprosy control activities (plan period 2006-2010) 2010, New Delhi, India: WHO, World Health Organization (WHO), New Delhi, India.
26. Raffe SF, Thapa M, Khadge S, Tamang K, Hagge D, Lockwood DN. Diagnosis and treatment of leprosy reactions in integrated services - the patients' perspective in Nepal. PLoS Negl Trop Dis 2013, 7(3):e2089. 10.1371/journal.pntd.0002089, 3591330, 23505585.
27. Douglas JT, Cellona RV, Fajardo TT, Abalos RM, Balagon MV, Klatser PR. Prospective study of serological conversion as a risk factor for development of leprosy among household contacts. Clin Diagn Lab Immunol 2004, 11:897-900. 515277, 15358649.
28. Bakker MI, Hatta M, Kwenang A, Van Mosseveld P, Faber WR, Klatser PR, Oskam L. Risk factors for developing leprosy--a population-based cohort study in Indonesia. Lepr Rev 2006, 77(1):48-61. Erratum in: Lepr Ver 2006, 77(2):170.
29. World Health Organization (WHO), Geneva, Switzerland WHO Expert Committee on Leprosy 1998, Geneva, Switzerland: WHO, World Health Organization (WHO), Geneva, Switzerland.
30. Croft RP, Smith WC, Nicholls P, Richardus JH. Sensitivity and specificity of methods of classification of leprosy without use of skin-smear examination. Int J Lepr Other Mycobact Dis 1998, 66(4):445-450.
31. Martelli CM, Stefani MM, Gomes MK, Rebello PF, Peninni S, Narahashi K, Maroclo AL, Costa MB, Silva SA, Sacchetim SC, Nery JA, Salles AM, Gillis TP, Krahenbuhl JL, Andrade AL. Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study. Int J Lepr Other Mycobact Dis 2000, 68(3):247-257.
32. Roche PW, Failbus SS, Britton WJ, Cole R. Rapid method for diagnosis of leprosy by measurements of antibodies to the M. leprae 35-kDa protein: comparison with PGL-I antibodies detected by ELISA and "dipstick" methods. Int J Lepr Other Mycobact Dis 1999, 67(3):279-286.
33. Young DB, Buchanan TM. A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science 1983, 221:1057-1059. 10.1126/science.6348948, 6348948.
34. Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ. Serological monitoring of the response to chemotherapy in leprosy patients. Int J Lepr Other Mycobact Dis 1993, 61(1):35-43.
35. Baumgart KW, Britton WJ, Mullins RJ, Basten A, Barnetson RS. Subclinical infection with Mycobacterium leprae-a problem for leprosy control strategies. Trans R Soc Trop Med Hyg 1993, 87(4):412-415. 10.1016/0035-9203(93)90016-J, 8249066.
36. Düppre NC, Camacho LA, Sales AM, Illarramendi X, Nery JA, Sampaio EP, Sarno EN, Bührer-Sékula S. Impact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort study. PLoS Negl Trop Dis 2012, 6(6):e1711. 10.1371/journal.pntd.0001711, 3378622, 22724040.
37. Frota CC, Freitas MV, Foss NT, Lima LN, Rodrigues LC, Barreto ML, Kerr LR. Seropositivity to anti-phenolic glycolipid-I in leprosy cases, contacts and no known contacts of leprosy in an endemic and a non-endemic area in northeast Brazil. Trans R Soc Trop Med Hyg 2010, 104(7):490-495. 10.1016/j.trstmh.2010.03.006, 20447668.